The Trump Administration’s weakening of regulatory benefit-cost analysis vests unequal power in executive review.
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback